Potential variations in levothyroxine formulated in the United States versus in Canada.
Stoffer
Sheldon S
SS
Szpunar
Walter E
WE
D002170:Canada; D002626:Chemistry, Pharmaceutical; D013810:Therapeutic Equivalency; D013974:Thyroxine / Q000737:chemistry* / Q000493:pharmacokinetics*; D014481:United States
D013974:Thyroxine